GLP-1 drugs like Ozempic and Wegovy lower the risk of 42 conditions
The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an assessment of how the drugs affect 175 conditions
Massive study looks at benefits, risks of GLP-1 weight-loss drugs
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has uncovered neurological and behavioral health benefits amid risks for pancreatitis and kidney disease.
GLP-1 drugs linked to lower dementia risk, higher risk of kidney, stomach issues
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, addiction, heart disease, and gastrointestinal problems, among others.
Taking Ozempic for weight loss? You might find other benefits, too - and a few risks
A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side effects.
Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risks
Several years ago, a little-known drug named Ozempic – previously used only to treat diabetes – emerged as a promising new drug for weight management. The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class of drugs called glucagon-like peptide-1 agonists,
Major study of weight-loss jabs shows slew of benefits but also risks
The risk of heart attack and stroke declines, but gastrointestinal problems and joint inflammation increase: New research has shed more light on the pros and cons of weight-loss jabs.
Weight-Loss Drugs Show Major Health Benefits but Carry Risks
A major study involving two million people has unveiled surprising effects of weight-loss drugs like Ozempic and Wegovy. While originally designed to treat type 2 diabetes, these medications have been linked to improved heart health fewer infections,
Ozempic and Wegovy: Scientists Uncover New Risks of Popular Weight-Loss “Miracle Drugs”
GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and gastrointestinal issues. Demand for weight-loss medications, including popular brands like Ozempic and Wegovy,
Merck and Eisai's cancer drugs fail to improve overall survival in late-stage trial
Merck's blockbuster drug Keytruda and Eisai's cancer drug Lenvima, in combination with chemotherapy, failed to improve ...
Miami-Dade Sheriff's deputy accused of selling drugs arrested
MIAMI - A Miami-Dade Sheriff's deputy accused of selling drugs has been arrested. According to the sheriff's office, an internal investigation identified Deputy Francisco Melo as a ...
Mexico should stop exporting drugs: Americans turn to memes after Trump doubles down on immigration
Donald Trump's latest immigration policies have ignited a wave of memes and controversy, as he aims to reinforce the border ...
Philippines to 'respond favourably' if ICC seeks Interpol arrest warrants over drugs crackdown
The Philippines will respond favourably if Interpol is asked by the International Criminal Court to issue arrest warrants ...
Trump signs death penalty order directing attorney general to help states get lethal injection drugs
President Donald Trump has signed a sweeping execution order on the death penalty that directs the attorney general to “take ...
How breakthroughs in AI are helping to design life-saving drugs faster than ever before
A team of scientists at the University of Toronto have successfully implemented AI tools to speed up the process of ...
Medicare to Negotiate Prices for 15 More Drugs, Including Ozempic
“Improving prescription drug affordability for Medicare enrollees is the core of the Inflation Reduction Act, and the next ...
Popular weight loss drugs could be cheaper for some Americans: What you need to know
If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...
CDSCO flags 135 drugs for failing quality standards for December 2024
Most drugs found NSQ by central labs this month were produced in units located in cities such as Ahmedabad, Vadodara, ...
FDA warns of serious allergic reactions with some multiple sclerosis drugs
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...